We are working with innovators in the food industry, providing cruelty free growth factors and cytokines which are shaping the future of the food and dairy industry.
At Leaf we use our SupraVec® technology to enable our partners in the development of therapeutic drugs, diagnostics and vaccines.
SupraVec enables us to lower costs making drugs more affordable and more widely available to a global population. The rapid production speed of SupraVec can deliver products to market much faster, subsequently reducing the time it takes to get new drugs to patients more affordably.
As far as we can tell there is no difference between LES MAb and hybridoma-produced MAb. Well done Leaf Expression SystemsCustomer Quote (diagnostics)